載入...
The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cells
Bortezomib is a novel anti-cancer agent which has shown promising activity in non-small lung cancer (NSCLC) patients. However, only a subset of patients respond to this treatment. We show that NSCLC cell lines are differentially sensitive to bortezomib, IC(50 )values ranging from 5 to 83 nM. The apo...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2007
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2194734/ https://ncbi.nlm.nih.gov/pubmed/18021420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-6-73 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|